EXCLUSIVE: Turkish Industry Pleads For Value-Based Approach
This article was originally published in PharmAsia News
Executive Summary
At the beginning of a new year, the Turkish Association of Research Based Pharmaceutical Companies (AIFD) is asking the government to adopt a “value based” approach to healthcare instead of focusing on costs and prices. In an exclusive interview, AIFD Secretary General and Chief Operating Officer Osman Kara highlights the potential of innovative pharmaceuticals and said that with a transparent and sustainable system, the industry could help Turkey to become a regional hub for healthcare.